Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Treatment with somatostatin analogs and chemoembolization of liver metastases for severe hypoglycemia in malignant insulinomas.

Maiza JC, Vezzosi D, Grunenwald S, Otal P, Guimbaud R, Bennet A, Caron P.

J Endocrinol Invest. 2011 Oct;34(9):e253-8. doi: 10.3275/7762. Epub 2011 May 27.

PMID:
21623151
2.

Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy.

van Schaik E, van Vliet EI, Feelders RA, Krenning EP, Khan S, Kamp K, Valkema R, van Nederveen FH, Teunissen JJ, Kwekkeboom DJ, de Herder WW.

J Clin Endocrinol Metab. 2011 Nov;96(11):3381-9. doi: 10.1210/jc.2011-1563. Epub 2011 Sep 14.

PMID:
21917872
3.

Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies.

Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B, Buscail L, Susini C, Caron P.

Eur J Endocrinol. 2005 May;152(5):757-67.

4.

Short- and long-term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism.

Vezzosi D, Bennet A, Courbon F, Caron P.

Clin Endocrinol (Oxf). 2008 Jun;68(6):904-11. Epub 2007 Nov 19.

PMID:
18031316
5.

Prompt resolution of hypoglycemia by hepatic transarterial embolization for malignant insulinoma with multiple liver metastases.

Muro S, Nasu J, Harada R, Matsubara M, Nakarai A, Kanzaki H, Tsutsumi K, Kato H, Tanaka T, Fujiwara H, Uno M, Okada H, Yamamoto K.

Acta Med Okayama. 2014;68(5):303-6.

6.
7.

[Malignant insulinoma].

Tóth M, Szücs N, Jakab Z, Doros A, Nemes Z, Rácz K.

Orv Hetil. 2011 Mar 6;152(10):398-402. doi: 10.1556/OH.2011.29058. Hungarian.

PMID:
21354956
8.

[Recurrent hypoglycemia caused by malignant insulinoma: chemoembolization as a therapeutic option].

Schütt M, Lorch H, Krüger S, Klingenberg RD, Peters A, Klein HH.

Med Klin (Munich). 2001 Oct 15;96(10):632-6. German.

PMID:
11715335
9.

A case of malignant insulinoma: successful control of glycemic fluctuation by replacing octreotide injections with octreotide LAR injections.

Okamoto M, Kishimoto M, Takahashi Y, Osame K, Noto H, Yamamoto-Honda R, Kajio H, Tokuhara M, Edamoto Y, Endo H, Igari T, Kubota K, Noda M.

Endocr J. 2013;60(8):951-7. Epub 2013 May 11.

10.

In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.

Robben JH, Visser-Wisselaar HA, Rutteman GR, van Rijk PP, van Dongen AJ, Voorhout G, van den Ingh TS, Hofland LJ, Lamberts SW.

J Nucl Med. 1997 Jul;38(7):1036-42.

11.

Diagnostic usefulness of radiolabeled pentetreotide scintigraphy and therapeutic efficiency of octreotide in a case of insulinoma.

Cuvelier C, Pochet JM, Col V, Jonard P, Pauwels S, Cuvelier A.

Acta Clin Belg. 1994;49(6):296-301.

PMID:
7871936
12.

[Selective therapeutic embolization in malignant insulinoma].

Civera Andrés M, Real Collado JT, Martínez Usó I, Ampudia Blasco FJ, Carmena Rodríguez R.

Rev Clin Esp. 2000 Oct;200(10):548-50. Spanish.

PMID:
11153238
13.

Multiple effects of somatostatin analogs verified in three cases of metastasized neuroendocrine tumors of the gastroenteropancreatic system.

Biliotti G, Martini F, Vaggelli L, Messerini L, Colagrande S, Pupi A, Seghi P.

Tumori. 2006 Mar-Apr;92(2):170-4.

PMID:
16724698
14.

Treatment: symptomatic treatment of hypoglycaemia.

Tabarin A, Goichot B; French Endocrine Society.

Ann Endocrinol (Paris). 2013 Jul;74(3):196-9. doi: 10.1016/j.ando.2013.05.009. Epub 2013 Jun 18. No abstract available.

PMID:
23791453
15.

Octreotide for the treatment of sulfonylurea poisoning.

Glatstein M, Scolnik D, Bentur Y.

Clin Toxicol (Phila). 2012 Nov;50(9):795-804. doi: 10.3109/15563650.2012.734626. Epub 2012 Oct 10. Review.

PMID:
23046209
16.

[Treatment of metastatic malignant insulinomas. 2 cases].

Mounedji-Boudiaf L, Rougier P, Culine S, de Baere T, Lasser P, Escudier B, Ducreux M, Kaloustian E, Droz JP, Roche A.

Presse Med. 1995 May 27;24(19):894-6. French.

PMID:
7638129
17.

Successful control of intractable hypoglycemia using radiopharmaceutical therapy with strontium-89 in a case with malignant insulinoma and bone metastases.

Naganuma A, Mayahara H, Morizane C, Ito Y, Hagihara A, Kondo S, Ueno H, Itami J, Okusaka T.

Jpn J Clin Oncol. 2012 Jul;42(7):640-5. doi: 10.1093/jjco/hys055. Epub 2012 Apr 23.

18.

Combined octreotide and peptide receptor radionuclide therapy ((90)Y-DOTA-TATE) in case of malignant insulinoma.

Fischbach J, Gut P, Matysiak-Grześ M, Klimowicz A, Gryczyńska M, Waśko R, Ruchała M.

Neuro Endocrinol Lett. 2012;33(3):273-8.

PMID:
22635083
19.

Malignant metastatic insulinoma-postoperative treatment and follow-up.

Starke A, Saddig C, Mansfeld L, Koester R, Tschahargane C, Czygan P, Goretzki P.

World J Surg. 2005 Jun;29(6):789-93.

PMID:
15880279
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk